CCND1-BCL2 Gene Network: A direct target of Amifostine in human acute megakaryocytic leukemia cells

Related Experiment Video

Updated: Mar 13, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.6K

Feng Zhang1,2, Bo Yang3, Kailiang Zhang4

  • 1National Engineering Laboratory for Drug gable Gene and Protein Screening, Northeast Normal University, Changchun, Jilin, China.

Chemical Biology & Drug Design
|October 21, 2016
PubMed

Insights

Amifostine effectively treats acute megakaryocytic leukemia by inducing cell cycle arrest and apoptosis. It targets the CCND1-BCL2 gene network, offering a potential new therapeutic strategy for AML.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Amifostine (2-(3-aminopropyl) aminoethyl phosphorothioate) is a cytoprotective agent.
  • Amifostine exhibits significant biological effects on tumor cells.
  • Its therapeutic potential in hematological malignancies warrants investigation.

Purpose of the Study:

  • To investigate the efficacy of amifostine against human acute megakaryocytic leukemia (Dami cells).
  • To elucidate the underlying mechanisms of amifostine's action on leukemia cells.
  • To identify potential molecular targets for amifostine therapy in AML.

Main Methods:

  • Cell viability and apoptosis assays were performed on Dami cells treated with amifostine.
  • Cell cycle analysis was conducted to determine cell cycle distribution.
  • Whole-genome microarray and bioinformatics analyses were employed to identify affected genes.

Main Results:

  • Amifostine induced G2/M phase cell cycle arrest in Dami cells.
  • Amifostine treatment resulted in significant apoptosis of Dami cells.
  • Gene expression analysis revealed amifostine's impact on CCND1, BCL2, and CASP3.

Conclusions:

  • Amifostine demonstrates potent anti-leukemic effects on acute megakaryocytic leukemia cells.
  • The CCND1-BCL2 gene network is identified as a direct molecular target of amifostine.
  • This study suggests amifostine as a potential therapeutic agent for specific human AML subtypes.
Keywords:
CCND1CCND1-BCL2 Gene Networkamifostinetherapeutic target

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

890
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.8K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.5K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.2K